Argentum 47, Inc.
Other OTCCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Robert Stephenson
- Full Time Employees
- 5
- Sector
- Financial Services
- Industry
- Insurance - Brokers
- Address
- 34 St. Augustines Gate Hedon United Kingdom HU12 8EX
- IPO Date
- Jan 7, 2013
- CIK
- 0001533106
- Website
- arg47.com
- Similar Companies
- Business
- Argentum 47, Inc. (ARGQ) operates as a diversified holding company focused on technology, web-based services, and marketing solutions across the United Kingdom, the United States, and Europe. The company provides proprietary artificial intelligence (AI) and automation technologies; advanced B2B and B2C lead generation marketing solutions, including branding, advertising, and disruptive AI-driven digital marketing; web-based data management, storage, and blockchain services; and AI-powered Software-as-a-Service (SaaS) platforms for marketing and lead generation. It serves business-to-business and business-to-consumer customers in sectors such as digital marketing, energy claims, sustainability initiatives like the UK Government's Eco4 Scheme, and biopharmaceutical training. Founded in 2009 and headquartered in Hull, United Kingdom, the company formerly operated as Global Equity International, Inc., before changing its name in March 2018. In January 2025, Argentum 47 completed the acquisition of Marelius Biopharma Group through an all-share transaction, integrating the UK-based firm's specialized training and educational services in regulatory compliance, aseptic practices, and manufacturing standards for the biopharmaceutical and pharmaceutical industries; simultaneously divested Argentum Data Solutions, returning 77,876,548 common shares to treasury to streamline operations and enhance shareholder value; and appointed Sean Nathan Lloyd as CEO to drive strategic focus on high-growth areas.
Argentum 47, Inc. Announces Acquisition of Marelius Biopharma Group, Divestiture of Argentum Data Solutions, and Leadership Transition
Argentum 47, Inc. Announces Acquisition of Marelius Biopharma Group, Divestiture of Argentum Data Solutions, and Leadership Transition
Argentum 47 is Revolutionizing Business Energy Claims in the UK with Arg AI
Argentum 47, Inc. Embraces the Future by Advancing SaaS Build, Moving to Prestigious New Address, and Pioneering AI Lead Generation for UK Government's Eco4 Scheme
Argentum 47, Inc. Issues Q3 2023 Letter to Shareholders
Argentum 47, Inc. Moves into Online Cloud Business with New SaaS Module
Argentum 47 Inc. Ventures into the European Medical Cannabis Industry to Capitalize on the Growing Market
Argentum 47, Inc. Provides Business Update on Growth Initiatives